Massive transfusion for life-threatening bleeding in children
Treatments studied
Part of Injuries & trauma clinical trials.
This study tests whether adding the drug tranexamic acid (TXA) to a massive blood transfusion helps control life-threatening bleeding in children who are severely injured. It compares two groups: one gets TXA and the other gets a placebo (a dummy drug with no active ingredient).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 18 years old and have a serious traumatic injury.
- The hospital has activated a 'massive transfusion protocol' because your child has or is suspected to have severe, life-threatening bleeding.
- Your child must have at least 2 out of 3 signs of severe bleeding: low blood pressure, very fast heartbeat, or clear signs of a serious injury.
- Your child does not have a devastating brain injury that doctors believe is not survivable.
- Your child has not already received another study drug or been enrolled in this trial before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can improve outcomes for children with certain serious head or torso injuries. It aims to reduce complications from internal bleeding when the medicine is given soon after the injury.
This trial compares giving whole blood versus standard care in adults with severe trauma and dangerous blood loss (hemorrhagic shock). The goal is to see if whole blood helps stabilize patients faster and improves outcomes after major bleeding.
This trial compares different blood transfusion approaches for people in hemorrhagic shock from trauma or severe bleeding in the upper digestive tract. It aims to find the safest and most effective way to give blood in emergency situations.
This trial tests whether giving calcium and vasopressin early can improve outcomes in people with major injury who are at risk for life-threatening bleeding shock. It mainly includes patients who need rapid blood transfusion and likely major surgery to stop bleeding.
This study tests whether giving low-titer type O whole blood (or related blood products) works better for treating serious bleeding after a traumatic injury. It’s for adults who start blood transfusions right away under a massive bleeding plan.
This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.
Hear when a new Hemorrhagic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.